The General Hospital Corporation;The Regents of the University of California
发明人:
申请号：
EP15853792.8
公开号：
EP3212633B1
申请日:
2015.10.30
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Provided herein are compounds and methods for treating a disorder associated with aberrant A3 peptide levels, including Alzheimer's disease. Provided herein are compositions and methods for treating a disorder associated with aberrant AP peptide levels, including AD. Provided herein are compounds of Formula (A) or a pharmaceutically acceptable salt thereof, wherein, L' is selected from the group consisting of C(O), C(R1)(R2), substituted or unsubstituted -C2-6 alkylene-, and substituted or unsubstituted -C3-6 cycloalkylene.
